The “Immuno-Oncology” window is closing, but a massive capital shift toward Cancer Neuroscience is creating the next wave of opportunity. We analyzed 3,000+ active NIH grants to map the specific “Neural Alpha” targets that are triggering funding right now. Download the full 2026 Strategic Brief to see the data before your competitors do.
https://escience.gumroad.com/l/neural-code-2026
